Opioid

Rx-opioid related deaths fall for the first time in 13 years

Rx-opioid related deaths fall for the first time in 13 years

By

The bad news: heroin-related deaths inched upwards.

FDA tempers opioid approval impact

FDA tempers opioid approval impact

By

The Center for Drug Evaluation and Research's director says there is a need for new opioids and cuts off dosing comparisons between extended-release and immediate-release opioids.

Vancouver tests prescription heroin

The north-of-the-border solution comes amid climbing heroin abuse in the US.

FDA approves abuse-deterrent Hysingla ER

The first approved hydrocodone formulated to discourage misuse raises a challenge to controversial Zohydro.

Unsealed court documents shed light on opioid marketing

Drug makers favor big spending on speakers' events and doctor outreach.

American Academy of Neurology releases opioid policy

The reveal comes days before hydrocodone products jump to a more restrictive access tier.

Advocates want FDA's Hamburg out

The reason: opioids.

Painkiller maker Acura gets NIH grant

The $300,000 grant will go towards an abuse-deterrent technology.

FDA wants more info on Acura pain drug

FDA wants more info on Acura pain drug

By

FDA feedback will influence a new clinical trial design, but the regulator's recent reaction was a bit of a surprise.

Daiichi increases efforts to break into opioid market

Daiichi increases efforts to break into opioid market

By

The drugmaker is collaborating with Charleston Laboratories in the development and commercialization of hydrocodone products. The deal means Daiichi Sankyo now has two pipeline opiates.

Daiichi increases efforts to break into opioid market

Daiichi increases efforts to break into opioid market

By

The drugmaker is collaborating with Charleston Laboratories in the development and commercialization of hydrocodone products. The deal means Daiichi Sankyo now has two pipeline opiates.

Zohydro to get marketing overhaul

Zohydro to get marketing overhaul

By

The painkiller's marketer will look to partner with another manufacturer to better target primary care physicians, and will also reexamine its sales territories.

FDA approves a new painkiller

Targiniq ER combines the prescription opioid oxycodone and naloxone, which is often used to treat overdoses.

FDA approves a new painkiller

Targiniq ER combines the prescription opioid oxycodone and naloxone, which is often used to treat overdoses.

Purdue pain drug gets priority status

Purdue pain drug gets priority status

By

Purdue Pharma expects the FDA to vote yea or nay on the drug by October.

Purdue pain drug gets priority status

Purdue pain drug gets priority status

By

Purdue Pharma expects the FDA to vote yea or nay on the drug by October.

Zohydro's second act

Zogenix is working on a less easily abused formulation of its controversial prescription painkiller.

CDC: US is biggest Rx opioid market

CDC: US is biggest Rx opioid market

By

The Centers of Disease Control reports that prescribers wrote enough painkiller prescriptions to give one bottle to every adult in the US in 2012.

Study: Opioid deaths outnumber heroin-associated ones

Study: Opioid deaths outnumber heroin-associated ones

By

Researchers at Montreal's McGill University survey the explosion in prescription painkiller use and abuse.

Seniors are major painkiller users

A USA today analysis shows Medicare painkiller prescriptions rose 30% between 2007 and 2012.

Top opioid prescribers not pain specialists

Express Scripts said that family and internal medicine doctors were the top opioid prescribers between 2011 and 2012.

Chicago sues painkiller companies

The Windy City seeks $9.5 million in damages in a lawsuit that accuses manufacturers of misleading consumers.

CA counties sue makers of painkillers

Orange and Santa Clara counties are suing painkiller makers like Purdue and Endo, a suit akin to deceptive ad cases launched against the tobacco industry.

FDA standing by its Zohydro approval

FDA standing by its Zohydro approval

By

The regulator defends its approval decision in a web post.

New painkillers stalk Zohydro

New painkillers stalk Zohydro

By

Two drugmakers, Purdue Pharma and Teva, have abuse-deterrent hydrocodone medications either under FDA review or in late-stage testing.

FDA reviews new painkiller

The candidate would be the first to put oxycodone and morphine in one capsule.

Massachusetts painkiller ban overruled

A District Court says Massachusetts cannot ban opioid painkiller Zohydro.

Massachusetts painkiller ban overruled

A District Court says Massachusetts cannot ban opioid painkiller Zohydro.

Massachusetts bans Zohydro

The Bay State is saying no to the controversial prescription painkiller.

Massachusetts bans Zohydro

The Bay State is saying no to the controversial prescription painkiller.


Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.

Email Newsletters